リンパ癌検査の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2449)
◆英語タイトル:Global Lymph Cancer Testing Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2449
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:105
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、リンパ癌検査の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(核医療検査、血液検査、生検、その他)、用途別市場規模(病院、クリニック、がんセンター)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・リンパ癌検査の市場動向
・企業の競争状況、市場シェア
・リンパ癌検査の種類別市場規模(核医療検査、血液検査、生検、その他)
・リンパ癌検査の用途別市場規模(病院、クリニック、がんセンター)
・リンパ癌検査の北米市場規模2016-2027(アメリカ、カナダ)
・リンパ癌検査の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・リンパ癌検査のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・リンパ癌検査の中南米市場規模2016-2027(メキシコ、ブラジル)
・リンパ癌検査の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Genomic Health、Bio Rad Laboratories、Siemens Healthcare、Abbott Laboratories、Canon Medical Systems、Agilent Technologies、MDx Health、Beckman Coulter、Myriad Genetics、Ambry Genetics)
・結論
【レポートの概要】

Market Analysis and Insights: Global Lymph Cancer Testing Market
The global Lymph Cancer Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lymph Cancer Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lymph Cancer Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lymph Cancer Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lymph Cancer Testing market.

Global Lymph Cancer Testing Scope and Market Size
Lymph Cancer Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lymph Cancer Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Nuclear Medical Tests
Blood Tests
Biopsy
Other

Segment by Application
Hospital
Clinic
Cancer Center

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Genomic Health
Bio Rad Laboratories
Siemens Healthcare
Abbott Laboratories
Canon Medical Systems
Agilent Technologies
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lymph Cancer Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nuclear Medical Tests
1.2.3 Blood Tests
1.2.4 Biopsy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Lymph Cancer Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Cancer Center
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Lymph Cancer Testing Market Perspective (2016-2027)
2.2 Lymph Cancer Testing Growth Trends by Regions
2.2.1 Lymph Cancer Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lymph Cancer Testing Historic Market Share by Regions (2016-2021)
2.2.3 Lymph Cancer Testing Forecasted Market Size by Regions (2022-2027)
2.3 Lymph Cancer Testing Industry Dynamic
2.3.1 Lymph Cancer Testing Market Trends
2.3.2 Lymph Cancer Testing Market Drivers
2.3.3 Lymph Cancer Testing Market Challenges
2.3.4 Lymph Cancer Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Lymph Cancer Testing Players by Revenue
3.1.1 Global Top Lymph Cancer Testing Players by Revenue (2016-2021)
3.1.2 Global Lymph Cancer Testing Revenue Market Share by Players (2016-2021)
3.2 Global Lymph Cancer Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lymph Cancer Testing Revenue
3.4 Global Lymph Cancer Testing Market Concentration Ratio
3.4.1 Global Lymph Cancer Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lymph Cancer Testing Revenue in 2020
3.5 Lymph Cancer Testing Key Players Head office and Area Served
3.6 Key Players Lymph Cancer Testing Product Solution and Service
3.7 Date of Enter into Lymph Cancer Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Lymph Cancer Testing Breakdown Data by Type
4.1 Global Lymph Cancer Testing Historic Market Size by Type (2016-2021)
4.2 Global Lymph Cancer Testing Forecasted Market Size by Type (2022-2027)

5 Lymph Cancer Testing Breakdown Data by Application
5.1 Global Lymph Cancer Testing Historic Market Size by Application (2016-2021)
5.2 Global Lymph Cancer Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Lymph Cancer Testing Market Size (2016-2027)
6.2 North America Lymph Cancer Testing Market Size by Type
6.2.1 North America Lymph Cancer Testing Market Size by Type (2016-2021)
6.2.2 North America Lymph Cancer Testing Market Size by Type (2022-2027)
6.2.3 North America Lymph Cancer Testing Market Size by Type (2016-2027)
6.3 North America Lymph Cancer Testing Market Size by Application
6.3.1 North America Lymph Cancer Testing Market Size by Application (2016-2021)
6.3.2 North America Lymph Cancer Testing Market Size by Application (2022-2027)
6.3.3 North America Lymph Cancer Testing Market Size by Application (2016-2027)
6.4 North America Lymph Cancer Testing Market Size by Country
6.4.1 North America Lymph Cancer Testing Market Size by Country (2016-2021)
6.4.2 North America Lymph Cancer Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Lymph Cancer Testing Market Size (2016-2027)
7.2 Europe Lymph Cancer Testing Market Size by Type
7.2.1 Europe Lymph Cancer Testing Market Size by Type (2016-2021)
7.2.2 Europe Lymph Cancer Testing Market Size by Type (2022-2027)
7.2.3 Europe Lymph Cancer Testing Market Size by Type (2016-2027)
7.3 Europe Lymph Cancer Testing Market Size by Application
7.3.1 Europe Lymph Cancer Testing Market Size by Application (2016-2021)
7.3.2 Europe Lymph Cancer Testing Market Size by Application (2022-2027)
7.3.3 Europe Lymph Cancer Testing Market Size by Application (2016-2027)
7.4 Europe Lymph Cancer Testing Market Size by Country
7.4.1 Europe Lymph Cancer Testing Market Size by Country (2016-2021)
7.4.2 Europe Lymph Cancer Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Lymph Cancer Testing Market Size (2016-2027)
8.2 Asia-Pacific Lymph Cancer Testing Market Size by Type
8.2.1 Asia-Pacific Lymph Cancer Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lymph Cancer Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lymph Cancer Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Lymph Cancer Testing Market Size by Application
8.3.1 Asia-Pacific Lymph Cancer Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lymph Cancer Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lymph Cancer Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Lymph Cancer Testing Market Size by Region
8.4.1 Asia-Pacific Lymph Cancer Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lymph Cancer Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Lymph Cancer Testing Market Size (2016-2027)
9.2 Latin America Lymph Cancer Testing Market Size by Type
9.2.1 Latin America Lymph Cancer Testing Market Size by Type (2016-2021)
9.2.2 Latin America Lymph Cancer Testing Market Size by Type (2022-2027)
9.2.3 Latin America Lymph Cancer Testing Market Size by Type (2016-2027)
9.3 Latin America Lymph Cancer Testing Market Size by Application
9.3.1 Latin America Lymph Cancer Testing Market Size by Application (2016-2021)
9.3.2 Latin America Lymph Cancer Testing Market Size by Application (2022-2027)
9.3.3 Latin America Lymph Cancer Testing Market Size by Application (2016-2027)
9.4 Latin America Lymph Cancer Testing Market Size by Country
9.4.1 Latin America Lymph Cancer Testing Market Size by Country (2016-2021)
9.4.2 Latin America Lymph Cancer Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Lymph Cancer Testing Market Size (2016-2027)
10.2 Middle East & Africa Lymph Cancer Testing Market Size by Type
10.2.1 Middle East & Africa Lymph Cancer Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lymph Cancer Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lymph Cancer Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Lymph Cancer Testing Market Size by Application
10.3.1 Middle East & Africa Lymph Cancer Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lymph Cancer Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lymph Cancer Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Lymph Cancer Testing Market Size by Country
10.4.1 Middle East & Africa Lymph Cancer Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lymph Cancer Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Genomic Health
11.1.1 Genomic Health Company Details
11.1.2 Genomic Health Business Overview
11.1.3 Genomic Health Lymph Cancer Testing Introduction
11.1.4 Genomic Health Revenue in Lymph Cancer Testing Business (2016-2021)
11.1.5 Genomic Health Recent Development
11.2 Bio Rad Laboratories
11.2.1 Bio Rad Laboratories Company Details
11.2.2 Bio Rad Laboratories Business Overview
11.2.3 Bio Rad Laboratories Lymph Cancer Testing Introduction
11.2.4 Bio Rad Laboratories Revenue in Lymph Cancer Testing Business (2016-2021)
11.2.5 Bio Rad Laboratories Recent Development
11.3 Siemens Healthcare
11.3.1 Siemens Healthcare Company Details
11.3.2 Siemens Healthcare Business Overview
11.3.3 Siemens Healthcare Lymph Cancer Testing Introduction
11.3.4 Siemens Healthcare Revenue in Lymph Cancer Testing Business (2016-2021)
11.3.5 Siemens Healthcare Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Lymph Cancer Testing Introduction
11.4.4 Abbott Laboratories Revenue in Lymph Cancer Testing Business (2016-2021)
11.4.5 Abbott Laboratories Recent Development
11.5 Canon Medical Systems
11.5.1 Canon Medical Systems Company Details
11.5.2 Canon Medical Systems Business Overview
11.5.3 Canon Medical Systems Lymph Cancer Testing Introduction
11.5.4 Canon Medical Systems Revenue in Lymph Cancer Testing Business (2016-2021)
11.5.5 Canon Medical Systems Recent Development
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Details
11.6.2 Agilent Technologies Business Overview
11.6.3 Agilent Technologies Lymph Cancer Testing Introduction
11.6.4 Agilent Technologies Revenue in Lymph Cancer Testing Business (2016-2021)
11.6.5 Agilent Technologies Recent Development
11.7 MDx Health
11.7.1 MDx Health Company Details
11.7.2 MDx Health Business Overview
11.7.3 MDx Health Lymph Cancer Testing Introduction
11.7.4 MDx Health Revenue in Lymph Cancer Testing Business (2016-2021)
11.7.5 MDx Health Recent Development
11.8 Beckman Coulter
11.8.1 Beckman Coulter Company Details
11.8.2 Beckman Coulter Business Overview
11.8.3 Beckman Coulter Lymph Cancer Testing Introduction
11.8.4 Beckman Coulter Revenue in Lymph Cancer Testing Business (2016-2021)
11.8.5 Beckman Coulter Recent Development
11.9 Myriad Genetics
11.9.1 Myriad Genetics Company Details
11.9.2 Myriad Genetics Business Overview
11.9.3 Myriad Genetics Lymph Cancer Testing Introduction
11.9.4 Myriad Genetics Revenue in Lymph Cancer Testing Business (2016-2021)
11.9.5 Myriad Genetics Recent Development
11.10 Ambry Genetics
11.10.1 Ambry Genetics Company Details
11.10.2 Ambry Genetics Business Overview
11.10.3 Ambry Genetics Lymph Cancer Testing Introduction
11.10.4 Ambry Genetics Revenue in Lymph Cancer Testing Business (2016-2021)
11.10.5 Ambry Genetics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ リンパ癌検査の世界市場規模・現状・予測2021年-2027年(Global Lymph Cancer Testing Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。